Logo for SAB Biotherapeutics Inc

SAB Biotherapeutics Investor Relations Material

Latest events

Logo for SAB Biotherapeutics

Corporate Presentation

19 Nov, 2024
Logo for SAB Biotherapeutics

Q3 2024

6 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from SAB Biotherapeutics Inc

Access all reports
SAB Biotherapeutics Inc. is a biotechnology company focused on developing immunotherapies using its proprietary DiversitAb platform. The company specializes in producing targeted, fully human polyclonal antibodies for infectious diseases, autoimmune disorders, and other conditions. SAB Biotherapeutics leverages genetically engineered cattle to generate scalable and high-potency antibody treatments. The company is headquartered in Sioux Falls, South Dakota, and its shares are listed on the NASDAQ.